MARKET OUTLOOK
- US: After a weak start, US markets rose at the end of the week thanks to better than expected November retail sales data and helped by reassuring earnings reports and technical buying. Stocks from banks, financial, insurance, telecom and energy outperformed the market while transport, auto and real estate sectors lost ground. Technically, the starting new rise should continue during the week.
- EUROPE: European markets had a strong positive week as almost all indexes have reached new year highs. Again, all sectors closed the week on a positive note helped by stocks from telecom, retail, financial services and basic resources. The media sector remained flat over the week. Technically, the bias should remain bullish but indicators are overbought, calling for caution.
COMPANY PREVIEW
Morgan Stanley (USD 79.26 ; 0.83% ; MS ; MS.N)
Morgan Stanley is expected to announce on Tuesday its 4Q/Nov results. EPS may reach $1.77 ($1.38 a year ago). The Co should post strong EPS results. Analysts will review MS's performance in institutional securities, asset management, credit cards, prime brokerage, and trading. Last week, Goldman Sachs reported 4Q EPS of $6.59 ($6.17 expected).
Lennar Corp (USD 53.02 ; 1.4% ; LEN ; LEN.N)
Lennar will also report on Tuesday. The group is expected to announce 4Q/Nov EPS of $1.06 ($3.54 a year ago) on a revenue of $3.95bln ($5.03bln). In September, the group said profit fell in 3Q, the first decline in six years, after a slump in demand forced the company to offer incentives to buyers. During the same period, net new orders fell about 5%, less than competitors KB Home or Beazer Homes which reported declines of more than 40%.
Biomet (USD 42 ; 5.26% ; BMET ; BMET.O)
On Wednesday, Biomet delivers its quarterly earnings. The Co is expected to reach 2Q/Nov EPS of $0.44 ($0.41 a year ago) on a revenue of $526.8m ($494.7m). Last Monday shares of Biomet rose after a report that Smith and Nephew may bid more than £5bln for the company.
Nike (B) (USD 96.05 ; -1.02% ; NKE ; NKE.N)
The same day, Nike is seen reporting 2Q/Nov EPS of $1.12 ($1.14 a year ago) on a revenue of $3.75bln ($3.47bln). The market looks for sales growth to be slightly better than 1Q of 8.6% with some gross margin improvement for the group. Analysts believe this will be offset by higher demand creation and stock option expense.
General Mills (USD 57.65 ; 0.58% ; GIS ; GIS.N)
Finally, General Mills will report earnings on Thursday. The group may say 2Q/Nov EPS reached $1.03 ($1.01 a year ago) on a revenue of $3.42bln ($3.27bln). Last Friday, Fitch affirmed the group's IDR at 'BBB+', Senior Unsecured debt at 'BBB+' and Commercial Paper at 'F2'.
European markets enjoy strong week
After a weak start, US markets rose towards the end of the week due to positive retail sales data and reassuring earnings reports and technical buying. European markets enjoyed a strong week, with almost all indexes reaching new year highs. Markets on both sides of the Atlantic should see lifts this week.
Monday, December 18 - 2006 at 13:26
InternaxxMonday, December 18 - 2006 at 13:26 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
This Article was updated on Sunday, April 22 - 2007
Readers' recommendation
This story is currently rated 5.74 of 10 based on 34 readers' recommendations
This story is currently rated 5.74 of 10 based on 34 readers' recommendations
Disclaimer:
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
Browse related articles



Web Feeds